Journals / European Journal of Breast Health / 2018 / Cilt: 14 - Sayı: 2

Sentinel Lymph Node Metastasis in Invasive Lobular Carcinoma of the Breast

Pages
117–120
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this study, tumor size was the only independentclinical parameter that was found related to SLN metastases.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:ABSTRACTObjective: Invasive lobular carcinoma (ILC) of the breast makes up 5 to 15 percent of all invasive breast cancers.
📊
Key Findings & Data:This study intends to describe factors influencing sentinel lymphnode (SLN) positivity in patients with “pure” ILC.Materials and Methods: Data of 105 patients, who were treated at a tertiary oncology center, with lobular carcinoma of the breast that weresubjected to SLN biopsy was probed retrospectively.
💡
Conclusion & Impact:In this study, tumor size was the only independentclinical parameter that was found related to SLN metastases.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

ABSTRACTObjective: Invasive lobular carcinoma (ILC) of the breast makes up 5 to 15 percent of all invasive breast cancers. It has distinctive clinical andhistopathological features when compared to invasive ductal carcinoma (IDC). This study intends to describe factors influencing sentinel lymphnode (SLN) positivity in patients with “pure” ILC.Materials and Methods: Data of 105 patients, who were treated at a tertiary oncology center, with lobular carcinoma of the breast that weresubjected to SLN biopsy was probed retrospectively. Patients were categorized as ≤60 and >60 years of age, positive or negative for estrogen receptorand progesterone, tumor grade I, II and III, Ki67≤15% and >30%, lymphovascular invasion presence and the presence of multicentricity andmultifocality.Results: Mean age at the time of diagnosis was 52 (38-81). Mean tumor size was 2.7 cm (0.7-13cm). Univariate analyses revealed a significantrelationship between tumor size (≤2 cm vs >2cm) and metastasis in the SLN. This relation kept its significance in multivariate analyses. (p=0.013).Conclusion: With so many different characteristics from IDC, ILC is mostly a uniform tumor. In this study, tumor size was the only independentclinical parameter that was found related to SLN metastases.

🔖

Cite This Article

GÜLÇELİK, M. A., ÖZASLAN, C., GÜVEN, H. E., KÜLTÜROĞLU, M. O. (2022). Sentinel Lymph Node Metastasis in Invasive Lobular Carcinoma of the Breast. European Journal of Breast Health, Cilt: 14 - Sayı: 2, 117–120. https://ajindex.com/articles/510839

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Grube BJ, Hansen NM, Ye X, Giuliano AE. Tumor characteristics predictive of sentinel node metastases in 105 consecutive patients with invasive lobular carcinoma. Am J Surg 2002
  2. (PMID: 12383906) [CrossRef Roberts A, Nofech-Mozes S, Youngson B, McCready DR, Al-Assi M, Ramkumar S, Cil T. The Importance of Applying ACOSOG Z0011 Criteria in the Axillary Management of Invasive Lobular Carcinoma: A Multi-institutional Cohort Study. Ann Surg Oncol 2015
  3. (PMID: 26215196) [CrossRef ] Wang J, Mittendorf EA, Sahin AA, Yi M, Caudle A, Hunt KK, Wu Y. Outcomes of sentinel lymph node dissection alone vs. axillary lymph node dissection in early stage invasive lobular carcinoma: a retrospective study of the surveillance, epidemiology and end results (SEER) database. PLoS One 2014
  4. e89778. (PMID: 24587029) [CrossRef ] Fernández B, Paish EC, Green AR, Lee AH, Macmillan RD, Ellis IO, Rakha EA. Lymph-node metastases in invasive lobular carcinoma are different from those in ductal carcinoma of the breast. J Clin Pathol 2011
  5. (PMID: 21712309) [CrossRef ] Rakha EA, Gill MS, El-Sayed ME, Khan MM, Hodi Z, Blamey RW, Evans AJ, Lee AH, Ellis IO. The biological and clinical characteristics of breast carcinoma with mixed ductal and lobular morphology. Breast Cancer Res Treat 2009
  6. (PMID: 18404368) [CrossRef ] Rakha EA, El-Sayed ME, Powe DG, Green AR, Habashy H, Grainge MJ, Robertson JF, Blamey R, Gee J, Nicholson RI, Lee AH, Ellis IO. Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes. Eur J Cancer 2008
  7. (PMID: 18035533) [CrossRef ] McCart Reed AE, Kutasovic JR, Lakhani SR, Simpson PT. Invasive lobular carcinoma of the breast: morphology, biomarkers and ‘omics. Breast Cancer Res 2015
  8. (PMID: 25849106) [CrossRef ] Barroso-Sousa R, Metzger-Filho O. Differences between invasive lobular and invasive ductal carcinoma of the breast: results and therapeutic implications. Ther Adv Med Oncol 2016
  9. (PMID: 27482285) [CrossRef ] Topps A, Clay V, Absar M, Howe M, Lim Y, Johnson R, Bundred N. The sensitivity of pre-operative axillary staging in breast cancer: comparison of invasive lobular and ductal carcinoma. Eur J Surg Oncol 2014
  10. (PMID: 24797703) [CrossRef ] Viale G, Zurrida S, Maiorano E, Mazzarol G, Pruneri G, Paganelli G, Maisonneuve P, Veronesi U. Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated